Focus Partners Advisor Solutions LLC Boosts Stock Holdings in Cigna Group $CI

Key Points

• Focus Partners Advisor Solutions LLC increased its holdings in Cigna Group by 46.3% during the first quarter, acquiring 1,361 additional shares, bringing their total ownership to 4,301 shares valued at $1,415,000.
• A variety of institutional investors boosted their stakes in Cigna Group, with Price T Rowe Associates increasing its holdings by 10.0% to nearly $4 billion, indicating strong institutional confidence in the company.
• Analysts have mixed target price assessments for Cigna Group's stock, with Deutsche Bank setting a target of $415.00, while others like Barclays reduced their price target from $385.00 to $354.00.

Focus Partners Advisor Solutions LLC increased its stake in Cigna Group (NYSE:CI - Free Report) by 46.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,301 shares of the health services provider's stock after purchasing an additional 1,361 shares during the period. Focus Partners Advisor Solutions LLC's holdings in Cigna Group were worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC boosted its holdings in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after buying an additional 318 shares during the period. Aptus Capital Advisors LLC lifted its position in Cigna Group by 9.3% during the fourth quarter. Aptus Capital Advisors LLC now owns 2,857 shares of the health services provider's stock worth $789,000 after purchasing an additional 244 shares during the period. Benjamin Edwards Inc. lifted its position in Cigna Group by 2.4% during the fourth quarter. Benjamin Edwards Inc. now owns 2,158 shares of the health services provider's stock worth $596,000 after purchasing an additional 50 shares during the period. Baird Financial Group Inc. lifted its position in Cigna Group by 29.3% during the fourth quarter. Baird Financial Group Inc. now owns 38,246 shares of the health services provider's stock worth $10,561,000 after purchasing an additional 8,667 shares during the period. Finally, Cary Street Partners Financial LLC bought a new stake in Cigna Group during the fourth quarter worth about $6,716,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Trading Up 0.4%

Shares of NYSE:CI traded up $1.25 during mid-day trading on Friday, hitting $305.28. The company had a trading volume of 1,157,697 shares, compared to its average volume of 1,538,986. The firm has a fifty day moving average price of $297.68 and a 200 day moving average price of $312.09. The company has a market capitalization of $81.49 billion, a PE ratio of 16.66, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. Cigna Group's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's payout ratio is currently 32.97%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CI. Wall Street Zen cut shares of Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a research report on Thursday, August 14th. Guggenheim reissued a "buy" rating and set a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of "Buy" and an average target price of $374.76.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company's stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by corporate insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.